Leonardo (Len) DeCandia

First Name
Leonardo (Len)
Last Name
DeCandia
Job Title
Former Chief Procurement Officer, Johnson & Johnson

Len is an award-winning Supply Chain/Procurement Executive with 40+ years of experience (25 years at the CSO/CPO level) at global pharmaceutical and consumer healthcare companies Johnson & Johnson, Estee Lauder, AmerisourceBergen and Roche. A subject matter expert in engineering, manufacturing, sourcing and supply chain management. Len is a pioneer and a transformational leader with a stellar record through building high performing teams in driving value and bottom-line impact achieved with advanced strategic practices in innovation sourcing, digital transformation, supplier and customer relationship management, corporate social responsibility and organizational productivity.

During Len’s most recent assignment as Global Chief Procurement Officer at Johnson & Johnson, the Procurement Team improved P&L contribution productivity by 70%. Additionally, the J&J social impact and diverse supplier spending more than doubled during Len’s tenure achieving over $5B by year end 2022. These accomplishments were recognized three years in a row (2020 to 2022) by Global Procurement Leaders as the winners of the top Procurement Team in Supplier Diversity practices.

Len is a thought leader at the vanguard of innovative, next-generation supply chain theory. He is the founding chair of the Center for Supply Chain Management at Rutgers University and also serves as the Vice Chair of the Rutgers Business School Advisory Board. He is on the Saint Peter’s Health Systems Board of Trustees (New Brunswick, NJ). Len was recognized as the global CPO of the year in 2021 and honored with the Global Procurement Leaders Lifetime Achievement Award and the Rutgers Business School Distinguished Alumni Award in 2022. He currently is an advisor to companies seeking to transform their procurement and broader supply chain management processes for productivity, governance and digitization, particularly in healthcare, pharmaceuticals, and adjacent industries.